Symbiox Investment & Trading Intrinsic Value
Symbiox Investment & Trading (SYMBIOX) median intrinsic value is ₹1.29 from 7 valuation models (range ₹1–₹5), vs current price ₹2.00 — -35.5% downside (Trading Above Calculated Value), margin of safety -55.0%. For current market price and key ratios, visit SYMBIOX stock price BSE.
SYMBIOX Valuation Methods Summary — DCF, Graham Number & P/E
Symbiox Investment & Trading intrinsic value across 7 models vs current price ₹2.00 — upside/downside and value range per method. See SYMBIOX price to book ratio to compare market price against book value per share.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹0.60 | ₹0.48 - ₹0.72 | -70.0% | EPS: ₹0.04, Sector P/E: 12x |
| Book Value Method | asset | ₹5.00 | ₹4.50 - ₹5.50 | +150.0% | Book Value/Share: ₹10.32, P/B: 0.8x |
| Revenue Multiple Method | revenue | ₹1.29 | ₹1.16 - ₹1.42 | -35.5% | Revenue/Share: ₹1.29, P/S: 1.0x |
| Simple DCF (5Y) | dcf | ₹5.00 | ₹4.00 - ₹6.00 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹0.60 | ₹0.54 - ₹0.66 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹0.60 | ₹0.54 - ₹0.66 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹3.05 | ₹2.75 - ₹3.35 | +52.5% | EPS: ₹0.04, BVPS: ₹10.32 |
SYMBIOX Intrinsic Value vs Market Price — All Valuation Models
Symbiox Investment & Trading fair value range ₹1–₹5 vs current market price ₹2.00 across 7 valuation models. Check SYMBIOX company valuation to track the company's total market size over time.
SYMBIOX Intrinsic Value Analysis — Undervalued or Overvalued?
Symbiox Investment & Trading median intrinsic value ₹1.29, current price ₹2.00 — Trading Above Calculated Value by 35.5%, margin of safety -55.0%.
What is the intrinsic value of SYMBIOX?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Symbiox Investment & Trading (SYMBIOX) is ₹1.29 (median value). With the current market price of ₹2.00, this represents a -35.5% variance from our estimated fair value.
The valuation range spans from ₹0.60 to ₹5.00, indicating ₹0.60 - ₹5.00.
Is SYMBIOX undervalued or overvalued?
Based on our multi-method analysis, Symbiox Investment & Trading (SYMBIOX) appears to be trading above calculated value by approximately 35.5%.
SYMBIOX Financial Health — Key Ratios vs Industry Benchmarks
Symbiox Investment & Trading financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Asset Turnover Ratio | 0.12x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
SYMBIOX Cash Flow Quality — Operating & Free Cash Flow
Symbiox Investment & Trading operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹4 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-3 Cr | ₹-3 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-5 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |